ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Surescripts Calls on the Industry to Make Pharmacists a Permanent Part of Patient Care Teams

As the COVID-19 Pandemic Public Health Emergency expires on May 11, 2023, Surescripts, the nation’s leading health information network, calls on the industry to make pharmacists a permanent part of patient care teams.

“The COVID-19 pandemic forced changes across the U.S. healthcare system practically overnight,” said Frank Harvey, Chief Executive Officer of Surescripts. “As we return to life ‘before COVID,’ instead of rolling back pandemic-era policies, we should consider maintaining changes that created efficiencies or improved patient access to care.”

Community pharmacists in particular saw expanded authority to administer vaccines and certain tests and conduct limited prescribing. By the end of 2022, pharmacy teams were administering two of every three COVID-19 vaccinations.

“Pharmacists will retain many aspects of their roles as clinical care providers until the end of 2024, beyond the expiration of the public health emergency,” Harvey explained. “But instead of reverting to life as it was pre-COVID, we should evaluate the benefit of making some changes permanent.”

Burnout is pushing 1 in 5 physicians and 2 in 5 nurses to leave their practice within two years. 66% of U.S. hospital and health system leaders reported running their facilities at less than full capacity because of staffing shortages. And 30% of all rural hospitals are at immediate risk of shutting down.

With nine in ten Americans living within five miles of a pharmacy, 77% of patients agree that pharmacists are integral members of the care team. In fact, a majority of Americans agree that some COVID-19 public health emergency policies that make it easier for patients to access healthcare from pharmacists and other pharmacy team members – including vaccinations – should be made permanent.

According to new data from Surescripts, nearly half of all counties in the United States have relative shortages of primary care providers (PCPs) – just one PCP for every 1,500 people, and 61% of those counties have a high volume of retail pharmacy locations that could help expand access to primary care.

“The expanded authority community pharmacists were given to administer vaccines, limited testing and expanded access to quality care for patients – especially in rural communities – is one change that many Americans agree should continue. But more changes to policy, technology and payment models are needed to ensure pharmacists are equipped to effectively compliment the care delivered by primary care providers and we are committed to advancing the technology and interoperability that will support evolving care teams across the country,” added Harvey.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and give healthcare professionals the trusted insights they need to serve patients. We convene the Surescripts Network Alliance® to enhance prescribing, better inform care decisions and advance healthcare as a whole. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us at twitter.com/surescripts.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.16
-0.51 (-0.22%)
AAPL  277.55
+0.58 (0.21%)
AMD  214.24
+8.11 (3.93%)
BAC  52.99
+0.51 (0.97%)
GOOG  320.28
-3.36 (-1.04%)
META  633.61
-2.61 (-0.41%)
MSFT  485.50
+8.51 (1.78%)
NVDA  180.26
+2.44 (1.37%)
ORCL  204.96
+7.93 (4.02%)
TSLA  426.58
+7.18 (1.71%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.